MPO and inflammatory bowel disease: In contrast, the existing IBD medicine, 5‐ASA, did not suppress DSS‐ or TNBS‐induced colonic hypersensitivity; however, it reduced the inflammatory indices, including MPO activity and eosinophil infiltration, in DSS rats.